Press Releases
Nutra Pharma to Exhibit at the 12th IDGA Battlefield Healthcare Summit in Washington, D.C.
Business Wire | 4 hours 22 minutes ago
Nutra Pharma Corp. (OTCBB:NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that it will be exhibiting its over-the-counter (OTC) and prescription pain relievers, Nyloxin OTC and Nyloxin Rx, at the 12th IDGA Battlefield Healthcare Summit in Washington, D.C. The IDGA Battlefield Healthcare Summit is considered one of the premier military healthcare conferences and the start to the IDGA’s Military H...... (more)
Introducing NEUTROGENA CLINICAL(TM) with ION2COMPLEX(TM) Technology
PRNewswire | 4 hours 23 minutes ago
LOS ANGELES, March 11 /PRNewswire/ -- After years of research and ten new technology patents, Neutrogena®, the #1 dermatologist-recommend skin care brand, introduces NEUTROGENA CLINICAL™, featuring a breakthrough new anti-aging technology known as ION2COMPLEX™ to revitalize the look of collagen-depleted skin.... (more)
Anika Therapeutics Announces Date of Fourth-Quarter and Year-End 2009 Financial Results Conference Call
Business Wire | 4 hours 23 minutes ago
Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it plans to issue its fourth-quarter and year-end 2009 financial results after the close of the market on Tuesday, March 16, 2010. The Company plans to hold a conference call the next day (Wednesday, March 17) at 9:00 a.m. ET to discuss its financial results, business highlights and outlook. In addition, the Company will answer questions concerning business and financial developments and trends, and other business and financial matt...... (more)
Allon's Phase 1 Trial Broadens Davunetide's Intranasal Safety and Dose Range
MarketWire | 4 hours 23 minutes ago
VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 03/11/10 -- ... (more)
BioSante Announces Positive Leukemia Vaccine Results
Business Wire | 5 hours 53 minutes ago
BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced positive results of a human clinical study that show that its GVAX Leukemia vaccine may be able to reduce or eliminate the last remaining cancer cells in some chronic myeloid leukemia (CML) patients taking the drug Gleevec (imatinib mesylate). All patients enrolled in the trial used Gleevec for at least one year and still had cancer cells present. The study was conducted by researchers at the Johns Hopkins Kimmel Cancer Center in B...... (more)
Advanced Life Sciences Receives FDA Guidance on Approval Pathway for Restanza in Community Acquired Bacterial Pneumonia and Biodefense Indications
PRNewswire | 5 hours 53 minutes ago
CHICAGO, March 11 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS), a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, announced today that the U.S. Food and Drug Administration (FDA) has provided guidance on the clinical program required to assess the approvability of Restanza™ (cethromycin), a novel oral once-a-day antibiotic...... (more)
Advanced Life Sciences Announces 2009 Fourth Quarter and Full Year Financial Results
PRNewswire | 5 hours 53 minutes ago
CHICAGO, March 11 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS), a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced its financial results for the fourth quarter and full year ended December 31, 2009.... (more)
Helix BioMedix Expands Skin Care Product Distribution into Key Asian Markets through Agreement with RubyDerm Bio, Inc.
Business Wire | 6 hours 23 minutes ago
Helix BioMedix, Inc. (OTCBB: HXBM), a developer of bioactive peptides, announced that the Company entered into an agreement with RubyDerm Bio, Inc. under which RubyDerm will assume responsibility, on an exclusive basis, for the distribution of certain of Helix BioMedix’s branded prestige skin care products to spas, beauty stores, hospitals, clinics, physicians, and consumers in South Korea, China and Japan.... (more)
Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter Fiscal Year 2010
PRNewswire | 6 hours 23 minutes ago
TUSTIN, Calif., March 11 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), a clinical-stage biopharmaceutical company developing innovative monoclonal antibodies for the treatment of cancer and serious viral infections, today announced financial results for the third quarter of fiscal year (FY) 2010 ended January 31, 2010. The company also provided an update on its clinical programs and corporate developments.... (more)
Seattle Genetics Expands Antibody-Drug Conjugate Patent Portfolio
Business Wire | 6 hours 23 minutes ago
Seattle Genetics, Inc. (Nasdaq: SGEN) announced today that the U.S. Patent and Trademark Office has issued a patent related to its antibody-drug conjugate (ADC) technology. U.S. Patent No. 7,659,241 covers cleavable linkers and potent auristatin drug payloads used in certain of Seattle Genetics’ ADC programs, most notably brentuximab vedotin (SGN-35), as well as many ADC programs in development by its collaborators. Brentuximab vedotin, an ADC that utilizes the vcMMAE drug-linker unit, is in ...... (more)
Spectrum Pharmaceuticals to Present at the 22nd Annual Roth Capital Markets Growth Conference on Monday, March 15
Business Wire | 6 hours 23 minutes ago
Spectrum Pharmaceuticals, Inc. (NasdaqGM:SPPI), a commercial-stage biotechnology company with a focus in oncology, announced today that an overview of the Company’s business strategy will be given at the 22nd Annual ROTH Capital Markets Conference on Monday, March 15, 2010, at 8:00 am Pacific Time. The conference is being held at the Ritz-Carlton Hotel in Laguna Niguel, California.... (more)
Scientists Discover Causative Genetic Mutation Associated with Common Inherited Neurological Disorder
Business Wire | 20 hours 23 minutes ago
Scientists using advanced genomic analysis technologies from Life Technologies Corporation (NASDAQ: LIFE) have sequenced an individual’s genome and identified the specific causative mutation associated with Charcot-Marie-Tooth Disease (CMT), one of the most common inherited neurological disorders currently affecting 1 in 2,500 individuals in the United States.... (more)
Dainippon Sumitomo Pharma America Announces FDA Acceptance of Lurasidone New Drug Application for Treatment of Schizophrenia
PRNewswire | 21 hours 53 minutes ago
FORT LEE, N.J., March 10 /PRNewswire/ -- Dainippon Sumitomo Pharma America, Inc. (DSPA), a U.S. subsidiary of Dainippon Sumitomo Pharma Co., Ltd. (DSP), today announced that the U.S. Food and Drug Administration (FDA) recently accepted for review the lurasidone New Drug Application (NDA) for the treatment of patients with acute schizophrenia. The NDA was submitted to FDA on December 30, 2009 and will receive a standard review.... (more)
Stem Cell Therapeutics Corp. Announces Publication of Phase IIa Stroke Data
MarketWire | 22 hours 23 minutes ago
CALGARY, ALBERTA -- (Marketwire) -- 03/10/10 -- Stem Cell Therapeutics Corp. ("SCT" or the "Company") (TSX VENTURE: SSS) wishes to announce the acceptance and publication of the paper entitled "The Beta-hCG + Erythropoietin in Acute Stroke ( BETAS) Study" by the journal "Stroke", on March 8, 2010. This paper was authored by Dr. Steven C. Cramer, from the University of California, Irvine, Dr. David Brown at Hoag Memorial Hospital Presbyterian, New Port Beach, Dr. Michael D. Hill of Foothills ...... (more)
Research and Markets: Ariad Pharmaceuticals Inc.-Deals & Alliances Report for 2010 Includes M&A Statistics and Recent Partnering News Updates by Date
Business Wire | 1 day 1 hour 53 minutes ago
Research and Markets(http://www.researchandmarkets.com/research/f005ee/ariad_pharmaceutic) has announced the addition of the "Ariad Pharmaceuticals Inc.-Deals & Alliances Report" company profile to their offering.... (more)
58 Press Releases | 
RSS Feed
Sign up for BIO SmartBrief
Latest Blog Postsview more
R-rated movies increase likelihood of underage children trying alcohol
Science Blog
U discovery gives insight into brain 'replay' process
Science Blog
Diabetes' link to eating disorders explored
Science Blog
Penn researchers identify immune cells that fight parasites may promote allergies and asthma
Science Blog
Companies in the news
- AstraZeneca PLC
- Biogen IDEC Inc.
- Bristol Myers Squibb
- CSL Limited
- Entelos, Inc.
- Enzon Pharmaceuticals
- Genta Inc
- GlaxoSmithKline plc